...
首页> 外文期刊>Journal of Molecular Structure >Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors
【24h】

Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors

机译:新喹啉-3-碳腈衍生物作为潜在的DNA-乙酶抑制剂的合成,对接,QSAR,探险和抗微生物评价

获取原文
获取原文并翻译 | 示例

摘要

Novel sixty three quinoline-3-carbonitrile derivatives were synthesized starting from 6-substituted-2-hydrazinyl quinoline-3-carbonitrile. The synthesized compounds were characterized by IR, H-1 NMR,C- 13 NMR and mass spectroscopy. Some compounds were evaluated for their antibacterial and antifungal activities using agar diffusion technique. The compounds exhibited higher inhibition zones were further tested to determine their minimum inhibitory concentrations (MIC) using a serial dilution technique. The results revealed that compounds 7(a), 7(g), 7(i), 7(l) and 7(o) have promising antimicrobial activities with MIC ranging from 12.5 to 25 mu g/mL. Furthermore, molecular docking studies were performed to investigate binding patterns of the synthesized compounds against DNA-gyrase (PDB: 2xct), using Accelrys Discovery studio 2.5 software. Moreover, a QSAR model was generated to explore the structural requirements controlling antimicrobial activities of the synthesized compounds against Bacillus subtilis. The synthesized compounds were analyzed for their ADMET properties. Results revealed the synthesized compounds have low ability to penetrate BBB, good to moderate aqueous solubility and non-inhibitory effect against CYP2D6. (C) 2018 Published by Elsevier B.V.
机译:从6-取代-2-肼喹啉-3-腈开始合成新型六十三种喹啉-3-腈衍生物。合成化合物的特征在于IR,H-1 NMR,C-13 NMR和质谱。使用琼脂扩散技术评估一些化合物的抗菌和抗真菌活性。将化合物表现出较高的抑制区,进一步测试使用连续稀释技术来确定其最小抑制浓度(MIC)。结果表明,化合物7(A),7(G),7(I),7(L)和7(O)具有前景的抗微生物活性,MIC为12.5至25μg/ mL。此外,使用Accelry Discovery Studio 2.5软件研究对DNA-乙酶(PDB:2XCT)的合成化合物的结合模式进行分子对接研究。此外,产生了QSAR模型以探讨控制合成化合物对枯草芽孢杆菌的抗微生物活性的结构要求。分析合成的化合物以进行浸泡性质。结果表明,合成化合物具有低渗透BBB的能力,良好的适度水溶性和针对CYP2D6的非抑制作用。 (c)2018由elestvier b.v出版。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号